LTLiam Li-An Tsou

Liam Li-An Tsou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Liam Li-An Tsou has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Great Escape? Investigations of Tunneling Contributions to the Valence Tautomerizations of Benzene Chalcogenides and Heteroepins

    by Liam Tsou, Muhammad Dilawar Danish, Daniel P. Miller, Tim Schleif

    Valence tautomerizations are prototypical pericyclic rearrangements with broad relevance in (bio)organic chemistry that can exhibit significant contributions from quantum mechanical tunneling (QMT), as demonstrated previously e.g., for the oxepin—benzene oxide equilibrium. Such contributions were evaluated computationally for the valence tautomerizations of heteroepins C 6 H 6 X (X = S, Se, and Te) and thiepin oxides (X = SO or SO 2 ). Ring contraction of the heteroepins becomes increasingly exothermic from X = O to X = Te; however, as an exception to the Bell–Evans–Polanyi principle, the associated activation barriers also increase. Analysis of the intrinsic reaction coordinates reveals that the critical C1–C6 distance in the heteroepins strongly widens within this series, resulting in increasingly wider and higher barriers despite the growing thermodynamic driving force. Consequently, estimated tunneling probabilities decrease dramatically across the series, ruling out tunneling as a significant contributor to the experimentally observed instability of thiepin, selenepin, and tellurepin. In contrast, the valence tautomerizations of thiepin‐ S ‐oxide and thiepin‐ S,S ‐dioxide follow conventional Bell–Evans–Polanyi behavior. The equatorial conformer of thiepin‐ S ‐oxide is expected to not exhibit any appreciable tunneling reactivity, while its axial conformer is projected to undergo rapid ring contraction by heavy‐atom tunneling. The bicyclic tautomer of C 6 H 6 SO 2 is predicted to ring‐expand to the less strained thiepin‐ S,S ‐dioxide with a half‐life suitable for matrix isolation spectroscopy experiments. Overall, this study of the potential role of QMT in the valence tautomerizations of heteroepins and thiepin oxides provides broader insights into how characteristic molecular features influence the intrinsic barrier width of a reaction.

  • Thiazide diuretics versus loop diuretics in stage 3-5 CKD: impact on cardiorenal outcomes

    by Li-Chin Sung, Hui-Wen Chiu, Samuel Mon-Wei Yu, Liam Li-An Tsou, Yung-Ho Hsu, Mai-Szu Wu, Cheng-Li Lin, Fuu-Jen Tsai, Chu-Lin Chou

    Objectives The association between diuretic use and cardiorenal outcomes remains limited in patients with stage 3-5 chronic kidney disease (CKD) and hypertension. To address this gap, we aim to investigate the long-term clinical impact of diuretic use with its pharmacological classification in Taiwanese patients with stage 3-5 CKD and hypertension who were concurrently received angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs). Methods Using data from the National Health Insurance Research Database (January 2008 to December 2019), we focused on individuals with stage 3-5 CKD receiving ACEIs/ARBs between 2010 and 2018. We categorized the cohort into non-diuretic, loop diuretic (furosemide), thiazide diuretic, and combination diuretic groups. We used a Cox proportional hazards regression model with propensity score matching to analyze the influence of diuretics on all-cause mortality, cardiovascular (CV) death, and cardiorenal adverse outcomes. Results The study included 59,719 patients, with 17,585 in the non-diuretic group and 42,134 in the diuretic group. Diuretics including furosemide use was significantly associated the risks of hospitalization for decompensated congestive heart failure (CHF), acute renal failure (ARF), end-stage renal disease (ESRD) requiring dialysis, CV mortality, and all-cause mortality (p-value <0.001). Thiazide diuretics showed no such adverse outcomes associations. The group receiving both thiazide and furosemide was more associated with all-cause mortality than the nondiuretic, thiazide, and furosemide monotherapy groups (all p-value <0.001). Conclusion Among stage 3-5 CKD patients on ACEIs/ARBs, loop diuretics exposure was associated with increased mortality and hospitalization for cardiorenal events, while thiazide diuretics exposure in isolation had no such associations. In the present data, we cannot evaluate the relationship between furosemide-associated adverse outcomes and worse renal function. These findings highlight the need for randomized controlled trials to assess the safety of loop diuretics in this population, urging caution in their prescription without a clear clinical indication.